Alzheimer’s disease (AD) accounts for 60–80% of all dementia cases, with women at higher risk due to both longevity and biological factors. Familial AD, ...
Torino, Italy, October 7 – Resalis Therapeutics, a biotechnology company pioneering microRNA-targeted therapies, presented new preclinical results on its lead candidate RES-010, a first-in-class ...
News-Medical.Net on MSN
Understanding the role of m6A methylation in acute lung injury pathogenesis
Acute lung injury (ALI) is a critical clinical condition characterized by diffuse inflammation of the lung parenchyma and ...
A new study published in Nature Biotechnology shows that stem cell differentiation is linked to cellular structures called ...
In this study, RES-010 demonstrated robust and durable weight reduction effects in obese NHPs maintained on a high-fat diet. After 10 weeks of treatment, RES-010 monotherapy achieved a 15% reduction ...
A man with neurofibromas who didn't know he's been clinically diagnosed with NF1, learns he harbors a deeply intronic, likely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback